Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis

J David Spence1, Victoria Coates, Hector Li

  • 1Stroke Prevention and Atherosclerosis Research Centre, 1400 Western Road, London, Ontario, Canada. dspence@robarts.ca

Archives of Neurology
|December 17, 2009
PubMed

Insights

Intensive medical therapy significantly reduced microemboli and cardiovascular events in patients with asymptomatic carotid stenosis (ACS). Revascularization is now less beneficial, with intensive medical management being the primary recommendation.

Area of Science:

  • Vascular Medicine
  • Neurology
  • Cardiology

Background:

  • Asymptomatic carotid stenosis (ACS) poses a risk for stroke.
  • Transcranial Doppler (TCD) can detect microemboli, indicators of embolic risk.
  • Previous management strategies for ACS focused on revascularization.

Purpose of the Study:

  • To evaluate the impact of intensified medical therapy on TCD microemboli and cardiovascular events in ACS patients.
  • To compare outcomes before and after the implementation of more intensive medical protocols since 2003.

Main Methods:

  • Prospective study conducted at a teaching hospital.
  • Included 468 patients with ACS (>60% stenosis).
  • Compared microemboli on TCD, cardiovascular events, and carotid plaque progression rates before and after 2003.

Main Results:

  • Microemboli decreased from 12.6% to 3.7% (P < .001) post-2003, correlating with better lipid control and slower plaque progression.
  • Cardiovascular events (stroke, MI, death, symptomatic endarterectomy) dropped from 17.6% to 5.6% (P < .001).
  • First-year carotid plaque progression rate significantly reduced from 69 mm² to 23 mm² (P < .001).

Conclusions:

  • Intensified medical therapy markedly reduces cardiovascular events and microemboli in ACS patients.
  • Less than 5% of ACS patients may benefit from revascularization.
  • Primary recommendation for ACS patients is intensive medical therapy, with revascularization considered only if microemboli are present on TCD.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...